Monthly revenue and year-on-year change for PEC (6446) and Handa Pharmaceuticals (6620) over the past 13 months. The chart compares year-on-year growth rather than amounts, since the companies differ in size.
Year-on-year change
Monthly revenue history
| Month | PEC | YoY | Handa Pharmaceuticals | YoY |
|---|---|---|---|---|
| Oct 2026 | NT$2.84 billion | +102.0% | NT$65.9 million | -24.8% |
| Sep 2026 | NT$2.64 billion | +100.0% | NT$70.4 million | -20.1% |
| Aug 2026 | NT$2.62 billion | +105.4% | NT$66.7 million | -79.9% |
| Jul 2026 | NT$2.51 billion | +92.6% | NT$69.7 million | +0.6% |
| Jun 2026 | NT$2.33 billion | +94.9% | NT$80.9 million | -21.8% |
| May 2026 | NT$2.46 billion | +108.5% | NT$71.3 million | -24.4% |
| Apr 2026 | NT$2.06 billion | +68.3% | NT$62.1 million | -88.9% |
| Mar 2026 | NT$1.94 billion | +64.4% | NT$78.7 million | +11.0% |
| Feb 2026 | NT$1.6 billion | +56.7% | NT$55 million | +4.2% |
| Jan 2026 | NT$1.58 billion | +49.8% | NT$75.7 million | +32.2% |
| Dec 2025 | NT$1.92 billion | +69.9% | NT$136.8 million | +106.5% |
| Nov 2025 | NT$1.55 billion | +53.0% | NT$75.8 million | +35.6% |
| Oct 2025 | NT$1.4 billion | +53.6% | NT$87.6 million | +34.4% |
← All Taiwan listed & OTC companies
Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16